(Q40494554)

21 September 2017

title

Proteasome inhibitor PS-341 causes cell growth arrest and apoptosis in human glioblastoma multiforme (GBM). (English)

1 reference

21 September 2017

0 references

1 reference

1 reference

6

Keith L Black

1 reference

21 September 2017

Dong Yin

1

1 reference

21 September 2017

Hong Zhou

2

1 reference

21 September 2017

Takashi Kumagai

3

1 reference

21 September 2017

Gentao Liu

4

1 reference

21 September 2017

John M Ong

5

1 reference

21 September 2017

H Phillip Koeffler

7

1 reference

21 September 2017

language of work or name

English

0 references

publication date

1 January 2005

1 reference

21 September 2017

1 reference

21 September 2017

volume

24

1 reference

21 September 2017

issue

3

1 reference

21 September 2017

page(s)

344-354

1 reference

Proteasome inhibition: a new strategy in cancer treatment

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1208225

Proteasome inhibitors potentiate leukemic cell apoptosis induced by the cyclin-dependent kinase inhibitor flavopiridol through a SAPK/JNK- and NF-κB-dependent process

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1208225

The role of NF-kappa B in TNF-related apoptosis-inducing ligand (TRAIL)-induced apoptosis of melanoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1208225

Expression of nuclear factor-kappa B, tumor necrosis factor receptor type 1, and c-Myc in human astrocytomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1208225

NF-kappa B as a therapeutic target in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1208225

Molecular mechanisms mediating antimyeloma activity of proteasome inhibitor PS-341.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1208225

The proteasome inhibitor PS-341 overcomes TRAIL resistance in Bax and caspase 9-negative or Bcl-xL overexpressing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1208225

Proteasome inhibitors induce mitochondria-independent apoptosis in human glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1208225

Wild-type p53 is a cell cycle checkpoint determinant following irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1208225

Molecular sequelae of proteasome inhibition in human multiple myeloma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1208225

Vitamin D compounds. Effect on clonal proliferation and differentiation of human myeloid cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1208225

Phase I trial of the proteasome inhibitor PS-341 in patients with refractory hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1208225

Apoptosis induction resulting from proteasome inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1208225

Proteasome inhibitors induce Fas-mediated apoptosis by c-Myc accumulation and subsequent induction of FasL message in human glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1208225

Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1208225

Proteasome inhibitors induce p53/p21-independent apoptosis in human glioma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1208225

NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1208225

p53 and E2F-1 cooperate to mediate apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1208225

Proteasome inhibitor PS-341 induces growth arrest and apoptosis of non-small cell lung cancer cells via the JNK/c-Jun/AP-1 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1208225

p53-dependent induction of apoptosis by proteasome inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1208225

inferred from DOI database lookup

7 January 2021

based on heuristic

Aberrant nuclear factor-kappaB activity and its participation in the growth of human malignant astrocytoma

1 reference

https://api.crossref.org/works/10.1038/SJ.ONC.1208225

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/SJ.ONC.1208225

1 reference

Dimensions Publication ID

21 September 2017

1036831705

0 references

1 reference